Postdiarrheal hemolytic uremic syndrome in United States children: Clinical spectrum and predictors of in-hospital death

Journal of Pediatrics

Volumn 166, Issue 4, 2015, Pages 1022-1029

  Mody, Rajal K ^a   Gu, Weidong ^a   Griffin, Patricia M ^a   Jones, Timothy F ^b   Rounds, Josh ^c   Shiferaw, Beletshachew ^d   Tobin D'Angelo, Melissa ^e   Smith, Glenda ^f   Spina, Nancy ^f   Hurd, Sharon ^g   Lathrop, Sarah ^h   Palmer, Amanda ⁱ   Boothe, Effie ^b   Luna Gierke, Ruth E ^a   Hoekstra, Robert M ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b TENNESSEE DEPARTMENT OF HEALTH   (United States)

^c MINNESOTA DEPARTMENT OF HEALTH   (United States)

^d OREGON PUBLIC HEALTH DIVISION   (United States)

^e GEORGIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^f New York State Emerging Infections Program   (United States)

^g Connecticut Emerging Infections Program ^*  (United States)

^h New Mexico Emerging Infections Program   (United States)

ⁱ MARYLAND DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; FRESH FROZEN PLASMA; ANTIINFECTIVE AGENT;

ADOLESCENT; ADVERSE OUTCOME; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CHILDHOOD MORTALITY; DIALYSIS; DIARRHEA; ERYTHROCYTE TRANSFUSION; FEMALE; HEMATOCRIT; HEMOLYTIC UREMIC SYNDROME; HUMAN; INFANT; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PLASMA TRANSFUSION; PREDICTIVE VALUE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RISK FACTOR; STREPTOCOCCUS PNEUMONIAE; THROMBOCYTE TRANSFUSION; UNITED STATES; COMPLICATION; ESCHERICHIA COLI INFECTIONS; FLUID THERAPY; FOLLOW UP; HEALTH SURVEY; HEMOLYTIC-UREMIC SYNDROME; MORTALITY; PRESCHOOL CHILD; PROCEDURES; PROGNOSIS; RETROSPECTIVE STUDY; TRENDS;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DIARRHEA; ESCHERICHIA COLI INFECTIONS; FEMALE; FLUID THERAPY; FOLLOW-UP STUDIES; HEMOLYTIC-UREMIC SYNDROME; HOSPITAL MORTALITY; HUMANS; INFANT; MALE; POPULATION SURVEILLANCE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 84933277999     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2014.12.064     Document Type: Article

References (29)

1. Oakes RS, Siegler RL, McReynolds MA, Pysher T, Pavia AT. Predictors of fatality in postdiarrheal hemolytic uremic syndrome. Pediatrics 2006; 117:1656-62.
2. Havens PL, O'Rourke PP, Hahn J, Higgins J, Walker AM. Laboratory and clinical variables to predict outcome in hemolytic-uremic syndrome. Am J Dis Child 1988;142:961-4.
3. Walters MD, Matthei IU, Kay R, Dillon MJ, Barratt TM. The polymorphonuclear leucocyte count in childhood haemolytic uraemic syndrome. Pediatr Nephrol 1989;3:130-4.
4. Robson WL, Leung AK, Brant R. The relationship of the admission hemoglobin to prognosis in children with D+ hemolytic uremic syndrome. Clin Nephrol 1991;36:212-3.
5. Mody RK, Luna-Gierke RE, Jones TF, Comstock N, Hurd S, Scheftel J, et al. Infections in pediatric postdiarrheal hemolytic uremic syndrome: factors associated with identifying Shiga toxin-producing Escherichia coli. Arch Pediatr Adolesc Med 2012;166:902-9.
6. Hothorn T, Hornik K, Zeileis A. Unbiased recursive partitioning: A conditional inference framework. J Comput Graph Stat 2006;15:651-74.
7. R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statisitcal Computing; 2013.
8. Coad NA, Marshall T, Rowe B, Taylor CM. Changes in the postenteropathic form of the hemolytic uremic syndrome in children. Clin Nephrol 1991;35:10-6.
9. Coulthard MG, Lambert HJ. Differing severity of D+ haemolytic uraemic syndrome in identical twins predicted from their neutrophil counts. Pediatr Nephrol 1994;8:528-9.
10. Milford DV, Staten J, MacGreggor I, Dawes J, Taylor CM, Hill FG. Prognostic markers in diarrhoea-associated haemolytic-uraemic syndrome: initial neutrophil count, human neutrophil elastase and von Willebrand factor antigen. Nephrol Dial Transplant 1991;6:232-7.
11. Robson WL, Leung AK, Fick GH, McKenna AI. Hypocomplementemia and leukocytosis in diarrhea-associated hemolytic uremic syndrome. Nephron 1992;62:296-9.
12. Teramoto T, Fukao T, Hirayama K, Asano T, Aoki Y, Kondo N. Escherichia coli O-157-induced hemolytic uremic syndrome: usefulness of SCWP score for the prediction of neurological complication. Pediatr Int 2009;51:107-9.
13. Zambrano OP, Delucchi BA, Cavagnaro SF, Hevia JP, Rosati MM, Lagos RE, et al. Hemolytic-uremic syndrome in Chile: clinical features, evolution and prognostic factors [in Spanish]. Rev Med Chil 2008;136: 1240-6.
14. Cimolai N, Morrison BJ, Carter JE. Risk factors for the central nervous system manifestations of gastroenteritis-associated hemolytic-uremic syndrome. Pediatrics 1992;90:616-21.
15. Ioannidis JP. Why most published research findings are false. PLoS Med 2005;2:e124.
16. Peng RD, Dominici F, Zeger SL. Reproducible epidemiologic research. Am J Epidemiol 2006;163:783-9.
17. Buteau C, Proulx F, Chaibou M, Raymond D, Clermont MJ, Mariscalco MM, et al. Leukocytosis in children with Escherichia coli O157:H7 enteritis developing the hemolytic-uremic syndrome. Pediatr Infect Dis J 2000;19:642-7.
18. Balestracci A, Martin SM, Toledo I, Alvarado C, Wainsztein RE. Dehydration at admission increased the need for dialysis in hemolytic uremic syndrome children. Pediatr Nephrol 2012;27:1407-10.
19. Ojeda J, Kohout I, Cuestas E. Dehydration upon admission is a risk factor for incomplete recovery of renal function in children with haemolytic uremic syndrome. Nefrologia 2013;33:372-6.
20. Ake JA, Jelacic S, Ciol MA, Watkins SL, Murray KF, Christie DL, et al. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion. Pediatrics 2005;115: e673-80.
21. Hickey CA, Beattie TJ, Cowieson J, Miyashita Y, Strife CF, Frem JC, et al. Early volume expansion during diarrhea and relative nephroprotection during subsequent hemolytic uremic syndrome. Arch Pediatr Adolesc Med 2011;165:884-9.
22. Davis TK, McKee R, Schnadower D, Tarr P. Treatment of Shiga toxin-producing Escherichia coli infections. Infect Dis Clin North Am 2013;27: 577-97.
23. Holtz LR, Neill MA, Tarr PI. Acute bloody diarrhea: A medical emergency for patients of all ages. Gastroenterology 2009;136:1887-98.
24. Banerjee R, Hersh AL, Newland J, Beekmann SE, Polgreen PM, Bender J, et al. Streptococcus pneumoniae-associated hemolytic uremic syndrome among children in North America. Pediatr Infect Dis J 2011;30:736-9.
25. Willing B, Russell S, Finlay BB. Shifting the balance: antibiotic effects on host-microbiota mutualism. Nat Rev Microbiol 2011;9:233-43.
26. Grif K, Dierich MP, Karch H, Allerberger F. Strain-specific differences in the amount of Shiga toxin released from enterohemorrhagic Escherichia coli O157 following exposure to subinhibitory concentrations of antimicrobial agents. Eur J Clin Microbiol Infect Dis 1998; 17:761-6.
27. Dundas S, Todd WT, Stewart AI, Murdoch PS, Chaudhuri AK, Hutchinson SJ. The central Scotland Escherichia coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death among hospitalized patients. Clin Infect Dis 2001;33:923-31.
28. Gould LH, Bopp C, Strockbine N, Atkinson R, Baselski V, Body B, et al. Recommendations for diagnosis of Shiga toxin-producing Escherichia coli infections by clinical laboratories. MMWR Recomm Rep 2009;58: 1-14.
29. Gerber A, Karch H, Allerberger F, Verweyen HM, Zimmerhackl LB. Clinical course and the role of Shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: A prospective study. J Infect Dis 2002;186:493-500.